Company Description

Channel Therapeutics, formerly Chromocell, Pelthos Therapeutics, and a Ligand company, is a pioneer in the development of non-opioid pain treatment therapeutics with a focus on modulating NaV1.7 receptors responsible for sensing and transmitting pain in the peripheral nervous system.